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Stent Recoil and Angiographic Outcome in Drug Eluting Stents. Results of the
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Background: Long-term efficacy of drug eluting stents (DES) can be influenced by
structural and drug-eluting cover characteristics, but the independent contribution of
these two aspects to long term DES performance remains unknown. Stent recoil (SR)
may reflect structural characteristics of DES, but its quantification in-vivo is difficult.
Methods: We prospectively investigated the role of SR in 4 different DES made of
stainless steel (A and B), cobalt chromium (C), and platinum chromium (D) in stable
patients. Eluted drugs were paclitaxel (A and B) and everolimus (C and D). SR was
measured using a novel methodology with digitally enhanced angiographic stent
imaging (DEASI). Absolute (mm) and relative (%) SR (%) was calculated from
measurements during and after deployment. 9-month angiographic follow-up was 70%.
Relevant QCA parameters, including late luminal loss (LLL), were measured.
Results: 97 DES (22 A, 25 B, 26 C and 24 D) were implanted. Larger stent diameters
in A and less calcification in C groups were noted. Overall absolute stent recoil was
0.27±0.13 mm, with significant differences between B (0.31±0.18 mm) and D
(0.23±0.14 mm, p=0.04). Overall relative SR was 8.66±4.10%.. Average LLL was
0.44±0.47 mm, with significant differences between DES, ranging from 0.25±0.20 (D)
to 0.94±0.78 (B) mm. Angiographic restenosis rates were 0% A (0/17), 23% B (3/13),
0% C (0/16) and 0% D (0/14). Univariate regression analysis showed a significant
relationship between SR and LLL (r=0.28, p=0.029). Multivariate regression analysis
with adjustment to stent nominal diameter, calcification, diabetes and DES type
identified SR (beta 1.20, p=0.007) and B type DES (beta 0.67, p<0.0001) as
independent predictors of LLL (r=0.65, p<0.0001).
Conclusion: 1) Marked variations in SR between different DES were documented in
vivo with a novel DEASI method. 2) Stent recoil was identified as an independent
significant predictor of LLL. 3) These observations stress the importance of SR and
suggest that both structural and anti-proliferative characteristics of DES influence long-
term angiographic outcome.
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Background: Previous intravascular ultrasound (IVUS) study revealed that first-
generation drug-eluting stents caused positive remodeling which could be related to
very late stent thrombosis. We evaluated peristent plaque change after zotarolimus-
eluting stents (ZES) implantation in comparison with paclitaxel-eluting stents (PES)
implantation, using gray-scale IVUS and integrated backscatter IVUS (IB-IVUS).
Methods: We randomly assigned 44 consecutive patients with de-novo lesions to treat
with ZES (n=22) and PES (n=22). Serial volumetric IVUS analysis was performed
after stenting and at 8-month follow-up. Peristent plaque (plaque outside stent struts)
components were analyzed in the whole stent segment with the largest vessel area at
baseline using IB-IVUS. We compared serial change of peristent plaque components
in the same segments in both groups, and evaluated the relationship between systemic
inflammation scores (white blood cell fraction and high-sensitive C-reactive protein)
and peristent plaque change.
Results: In PES, vessel volume in the whole stent segment significantly increased (356
to 380mm3, p<0.001), whereas it did not change in ZES (314 to 314mm3, p=0.99).
Serial IB-IVUS analysis showed fibrous plaque increased in both groups (PES: 3.0 to
3.6mm2, p=0.059, ZES: 2.9 to 4.0mm2, p<0.0001). Lipid plaque significantly
increased in PES (4.0 to 4.8mm2, p=0.02), however, that of ZES significantly
decreased (5.0 to 3.5mm2, p<0.0001). Lipid plaque change at the largest vessel area
was not related to any systemic inflammation scores in ZES. However, lipid plaque
change was significantly related to eosinophil change in PES (r=0.51, p=0.02). There
was no late and very late stent thrombosis up to 24-month follow-up in both groups.
Conclusion: Chronic peristent plaque change after PES implantation was completely
different from that after ZES implantion. Long-term clinical follow-up will be required
to confirm the impact of these findings obtained from this study.
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Distorted Balloon Shape During Predilatation Before Stenting Predicts Stent
Underexpansion
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Background: Suboptimal stent expansion has become recognized as an important risk
factor not only for drug-eluting stent (DES) failure (restenosis) but also for the more
serious and rare event of stent thrombosis. The cause of stent underexpansion seems
to be on the hardness of lesion, however, it is hard to know the information of such
lesion hardness from angiography. In this study, we focused on the shape of balloon
during pre-stent dilatation as a predictor of lesion hardness and as a result, stent
underexpansion.
Methods: We analyzed 147 stented lesions (104 patients) in which intravascular
ultrasound (IVUS) revealed calcified plaques. IVUS was performed before ballooning
and after DES (Taxus/Endeavor/XienceV) implantation. Predilatation balloon was
inflated until indentation disappeared, and then stent was implanted using standard
technique. We divided them into two groups according to balloon shape during
predilatation. Straighten shape (balloon shape angle < 5 degree on angiography; group
A, N=103) or distorted shape (looking curved or sigmoid; groupB, N=41) on
fluoroscopy. Minimal stent cross sectional area (CSA) and symmetry index were
analyzed from post-stent IVUS data. We also calculated the ‘estimated’ stent-CSA by
using compliance chart of each DES. Ratio of minimal/estimated stent-CSA (Min/E
ratio) was then calculated. M/E ratio and symmetry index were compared between two
groups.
Results: Baseline and lesion characteristics were similar between two groups.
However, M/E ratio in group B was significantly lower than in group A (0.56+-0.11
vs. 0.68+-0.10, p<0.001). Furthermore, symmetry index in group B was significantly
lower than in group A (0.77+-0.08 vs. 0.84+-0.06, p<0.001). These data suggested that
distorted shape of predilation balloon is strongly associated with stent underexpansion.
Conclusion: Distorted shape of balloon during predilatation can serve as a useful
predictor of DES underexpansion. To prevent the future serious events, higher pressure
stent implantation, and if required from IVUS result, post dilatation using high pressure
balloon is recommended when predilatation balloon looks distorted.
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Frequency and Distribution of Thin-Capped Fibroatheroma in the Left Main
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Background: We assessed the frequency and distribution of Virtual Histology
Intravascular Ultrasound (VH-IVUS) thin-capped fibroatheromas (VH-TCFA) in the
left main coronary artery (LM) in 423 pts.
Methods: VH-TCFA was defined as necrotic core (NC) >10% of plaque area within
a plaque burden of >40% and >30° NC abutting the lumen in at least 3 consecutive
frames. Positive remodeling was defined as a remodeling index (lesion/reference EEM
[external elastic membrane] area) >1.05.
Results: Overall, the frequency of VH-TCFA was only 10.4% (44/423); 30 in pts with
acute coronary syndrome and 14 in pts with stable angina. Pt age 63±12 yrs vs 61±11
yrs) and diabetes frequency (27% vs 27%) were similar in LM-TCFA vs LM without
TCFA. LM length and EEM area was similar in LM with vs without VH-TCFA;
however, minimal lumen area was smaller in LM-TCFA (p<0.0001, Table). Although
LM-TCFA had a higher plaque burden (p<0.0001), larger necrotic core area
(p<0.0001), and more dense calcium (p=0.0002) at the maximum NC site compared
to LM without TCFA, positive remodeling was present in only 18% (8/44) of LM-
TCFA. Overall, 59% of LM-TCFA were located in mid-body and the rest at the distal
bifurcation. Minimal lumen area was smaller in mid-body LM-TCFA vs distal LM-
TCFA (9.12±3.62 mm2 vs 11.89±3.34 mm2, p=0.017). Plaque composition including
necrotic core area was similar.
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